Masimo's ROA from the first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Masimo's ROA in the first quarter of 2026?
Masimo Corp achieved a return on average assets (ROA) of 4.04 % in its first quarter of 2026, which is below Masimo's average return on assets, which stands at 10.63%.

Despite the company's net income deteriorating, Masimo was able to improve its ROA compared to the fourth quarter of 2025.

However, within the Healthcare sector 171 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Apr 04 2026 quarter, so far to 1370, from total ROA ranking in the fourth quarter of 2025 at 3610.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Apr 04 2026) I. Quarter	(Jan 03 2026) IV. Quarter	(Sep 27 2025) III. Quarter	(Jun 28 2025) II. Quarter	(Mar 29 2025) I. Quarter
Y / Y Total Assets Change	-28.36 %	-49.48 %	-41.14 %	-16.98 %	-22.47 %
Y / Y Net Income Change	-	-	-	220.62 %	-
Net Income (TTM) in million	76	-152	-569	-459	-494
Return On Assets (TTM)	4.04 %	-7.38 %	-23.06 %	-16.48 %	-17 %
MASI's Total Ranking	# 1370	# 3610	# 3658	# 3521	# 3581
Total Assets (TTM) in million	1,643	1,699	1,818	2,403	2,293
Seq. Total Assets Change	-3.31 %	-6.53 %	-24.35 %	4.78 %	-31.81 %
Seq. Net Income Change	-16.4 %	-	-	-	-

MASI's 5 Years Annual ROA >> Back to MASI Management Effectiveness >> Compare MASI ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 49
Sector	# 172
Overall	# 1363

Return On Assets Statistics
High	Average	Low
44.81 %	10.63 %	-24.92 %
(Dec 31 2016)		(Sep 27 2025)

Financial Statements
Masimo's Assets	$ 1,643 million	MASI's Balance sheet
Masimo's Income	$ 57 million	Quarterly MASI's Income Statement
MASI's Income by Division		See MASI's Income by Division

Annual Return On Assets	(Jan 03 2026) FY 2025	(Dec 28 2024) FY 2024	(Dec 30 2023) FY 2023	(Dec 31 2022) FY 2022	(Jan 01 2022) FY 2021
Y / Y Total Assets Change	-35.3 %	-13.67 %	-5.27 %	70.14 %	10.19 %
Total Assets in million	1,699	2,626	3,042	3,211	1,887
Y / Y Net Income Change	-	-	-43.21 %	-37.51 %	-4.43 %
Net Income in million	-152	-305	82	144	230
Annual Return On Assets	-8.92 %	-11.61 %	2.68 %	4.47 %	12.17 %

MASI's 5 Years Annual ROA >> Back to MASI Management Effectiveness >> Compare MASI ROA to its Competitors

More Return On Assets Ratios
MASI's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MASI's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MASI's Competitors
Subscribers only: Roa for Masimo's Suppliers
Subscribers only: Return On Assets for MASI's Customers

You may also want to know
MASI's Roi	MASI's Inventory Turnover Ratio	MASI's Growth Rates	MASI's Dividend Comparisons
	MASI's Profitability Ratios	MASI's Asset Turnover Ratio	MASI's Dividend Growth
MASI's Roe	MASI's Valuation Ratios	MASI's Financial Strength Ratios	MASI's Dividend Payout Ratio

Companies with similar Return On Assets at Apr 04 2026, within Healthcare Sector	ROA
Regeneron Pharmaceuticals Inc	11.07 %
Johnson and Johnson	10.70 %
Ufp Technologies Inc	10.49 %
Lemaitre Vascular Inc	10.31 %
Embecta Corp	10.25 %
Cryoport inc	10.07 %
Universal Health Services Inc	10.06 %
Solventum Corporation	9.97 %
Kiniksa Pharmaceuticals International Plc	9.86 %
Mimedx Group Inc	9.73 %
Penumbra Inc	9.58 %
Pacific Health Care Organization Inc	9.57 %
Insulet Corporation	9.55 %
Progyny Inc	9.03 %
Siga Technologies Inc	8.94 %
Tenet Healthcare Corp	8.91 %
Utah Medical Products Inc	8.86 %
Amgen Inc	8.64 %
Lifevantage Corp	8.60 %
Entrada Therapeutics Inc	8.57 %
Lifemd Inc	8.49 %
Healthcare Services Group Inc	8.45 %
Boston Scientific Corporation	8.26 %
National Healthcare Corp	8.18 %
Edwards Lifesciences Corporation	8.13 %
Pediatrix Medical Group Inc	8.09 %
Nature s Sunshine Products inc	7.94 %
Infusystem Holdings Inc	7.93 %
Bristol myers Squibb Company	7.90 %
Viemed Healthcare Inc	7.85 %

Date modified: 2026-08-30T14:50:01+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.